CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271 | -34.9% | 49,179 | +0.8% | 0.00% | – |
| Q2 2023 | $416 | -21.7% | 48,768 | -15.6% | 0.00% | – |
| Q1 2023 | $531 | +69.6% | 57,789 | +88.5% | 0.00% | – |
| Q4 2022 | $313 | -99.6% | 30,659 | +533.3% | 0.00% | – |
| Q3 2022 | $71,000 | -62.4% | 4,841 | -72.6% | 0.00% | – |
| Q2 2022 | $189,000 | -46.2% | 17,651 | -45.9% | 0.00% | – |
| Q1 2022 | $351,000 | – | 32,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |